HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health, Beauty And Wellness Research News: Omegas And Cognitive Function, Spearmint And Memory, CR And Protein

This article was originally published in The Rose Sheet

Executive Summary

EPA, DHA and DPA may be good for executive function, while high levels of ARA may have negative impact on executive and cognitive functions; Kemin touts studies supporting cognitive and physical benefits of its spearmint extract ingredient; and Consumer Reports says 6 protein drinks "very good."

You may also be interested in...



Cognitive Conditions Fueling Demand For Dietary Ingredient Breakthroughs

Rising rates of Alzheimer’s disease and other cognitive conditions fuel demand for brain health supplements among consumers, with more than a third of US consumers saying they would be “very likely” to take them for memory, according to research firm Natural Marketing Institute.

Avantius Launches Supplement After Study Finds Formulation Slowed Alzheimer’s Progression

Memory Health supplement was developed and is launching in the US after a small European study of Alzheimer’s patients finds improvement in patients taking a carotenoid/omega-3 combination, says marketer Avantius Group. A larger-scale, double blinded clinical study is underway in Europe.

Takeda, Astellas Found New JV To Support Japanese Bioventures

Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel